Skip to main content

Chimeric Antigen Receptor (CAR) T-cells and Bispecific Antibodies (BsAbs): An Overview of Available Agents

Course Experts: Shahrier Hossain, PharmD, BCOP; Ashka Patel, PharmD, BCOP; Charles Ni, PharmD, MPH, BCOP; Emily Tiao, PharmD, BCOP

Course Description: This course covers the workings of CAR-T therapy and bispecific antibodies, assessing major trials, efficacy, safety, and managing side effects like cytokine release syndrome and neurotoxicity associated with these treatments.